Promega HiBiT-PsVLP Bioassay enables simple, safe study without infectious viral particles. Assay supports collaboration between Charles River and CEPI’s Centralised Laboratory Network. Technology ...

Therapeutic antibodies are now the major class of successful protein drugs with many more in development to target a variety of major diseases. An important and desirable biological activity of most ...

This is a preview. Log in through your library . Abstract An improved bioassay is described for a factor that promotes tumor growth which was first obtained from extracts of pinto bean leaves with ...

As the development of increasingly complex biologics grows, more robust bioassays are required to accurately characterize these molecules. Bioassays play a crucial role in biologic drug development as ...

Immunotherapy enables a patient’s own immune system to battle cancerous target cells instead of either attacking the target cells directly or using whole-body approaches. Programmed death receptor-1 ...

“This transaction enables Reaction Biology to add Bioassay GmbH’s impressive clinical phase and post-approval infrastructure, which includes large molecule capabilities, as well as its GMP and GLP ...

MADISON, Wis.--(BUSINESS WIRE)--Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from ...

Acquisition is the fourth for VION as it continues to expand its portfolio of proprietary products for life science research NASHVILLE, Tenn., February 05, 2025--(BUSINESS WIRE)--VION Biosciences, a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In 2021, BioAssay Works ...

The National Institute for Occupational Safety and Health (NIOSH) is currently studying mortality in a large pooled cohort of uranium-enrichment workers. As part of this study, organ dose from chronic ...